Lumos Pharma Analyst Ratings
BenzingaMar 21 00:26
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaMar 21 00:29
Lumos Pharma's LUM-201 Receives 'Buy' Rating on Strong Market Position and Promising Trial Outcomes
TipRanksMar 20 23:45
Lumos Pharma Analyst Ratings
BenzingaMar 8 19:50
Analysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Arcturus Therapeutics (ARCT)
TipRanksMar 8 19:30
Lumos Pharma Analyst Ratings
BenzingaDec 11, 2023 23:19
Oppenheimer Trims Lumos Pharma Price Target to $16 From $17, Maintains Outperform Rating
MT NewswiresDec 11, 2023 22:08
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaDec 7, 2023 19:43
Lumos Pharma Analyst Ratings
BenzingaDec 7, 2023 19:42
Analysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Rhythm Pharmaceuticals (RYTM)
TipRanksNov 8, 2023 19:20
Promising Results and Buy Rating for Lumos Pharma's Groundbreaking Growth Hormone Stimulant: LUM-201
TipRanksSep 26, 2023 22:46
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaSep 6, 2023 18:30
Lumos Pharma Analyst Ratings
BenzingaSep 6, 2023 18:29
Analysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV), Insmed (INSM) and Lumos Pharma (LUMO)
TipRanksSep 6, 2023 18:20
Lumos Pharma Analyst Ratings
BenzingaAug 22, 2023 21:54
Cantor Fitzgerald Maintains Overweight on Lumos Pharma, Lowers Price Target to $10
BenzingaAug 15, 2023 20:11
Lumos Pharma Analyst Ratings
BenzingaAug 15, 2023 20:11
Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Lumos Pharma (LUMO) and Curaleaf Holdings (OtherCURLF)
TipRanksAug 10, 2023 21:20
Oppenheimer Adjusts Lumos Pharma Price Target to $17 From $18, Maintains Outperform Rating
MT NewswiresAug 10, 2023 21:04
HC Wainwright & Co. Reiterates Buy on Lumos Pharma, Maintains $28 Price Target
BenzingaAug 10, 2023 18:35
No Data
No Data